Literature DB >> 24438328

TALE proteins bind to both active and inactive chromatin.

James N F Scott1, Adam P Kupinski1, Christopher M Kirkham1, Roman Tuma, Joan Boyes1.   

Abstract

TALE (transcription activator-like effector) proteins can be tailored to bind to any DNA sequence of choice and thus are of immense utility for genome editing and the specific delivery of transcription activators. However, to perform these functions, they need to occupy their sites in chromatin. In the present study, we have systematically assessed TALE binding to chromatin substrates and find that in vitro TALEs bind to their target site on nucleosomes at the more accessible entry/exit sites, but not at the nucleosome dyad. We show further that in vivo TALEs bind to transcriptionally repressed chromatin and that transcription increases binding by only 2-fold. These data therefore imply that TALEs are likely to bind to their target in vivo even at inactive loci.

Mesh:

Substances:

Year:  2014        PMID: 24438328     DOI: 10.1042/BJ20131327

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  3 in total

1.  Small-molecule inducible transcriptional control in mammalian cells.

Authors:  Aarti Doshi; Fatemeh Sadeghi; Navin Varadarajan; Patrick C Cirino
Journal:  Crit Rev Biotechnol       Date:  2020-08-30       Impact factor: 8.429

2.  Epigenetic features improve TALE target prediction.

Authors:  Annett Erkes; Stefanie Mücke; Maik Reschke; Jens Boch; Jan Grau
Journal:  BMC Genomics       Date:  2021-12-29       Impact factor: 3.969

Review 3.  Genome Engineering with TALE and CRISPR Systems in Neuroscience.

Authors:  Han B Lee; Brynn N Sundberg; Ashley N Sigafoos; Karl J Clark
Journal:  Front Genet       Date:  2016-04-06       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.